全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 307353-90-8 | 4-Chloro-6-methoxy-7-(phenylmethoxy)-3-quinolinecarboxylic acid ethyl ester | C20H18ClNO4 |
| 307492-75-7 | 1-Ethyl-2,3-dimethylimidazolium tetrafluoroborate | C7H13BF4N2 |
| 307494-95-7 | [(1,2,3-eta)-2-Butenyl]chloro(tricyclohexylphosphine)palladium | C22H40ClPPd |
| 307496-21-5 | trans-Chalcone-D12 | |
| 307496-22-6 | trans-4-Phenyl-3-Buten-2-One-D10 | |
| 307496-23-7 | 3-(2-Aminoethyl)Pyridine Dihydrobromide | C7H12Br2N2 |
| 307496-25-9 | Diethyldicyclopentadiene;Ethylcyclopentadiene dimer; 3,7-Diethyl-3a,4,7,7a-tetrahydro-4,7-methano-1H-indene | C14H20 |
| 307496-27-1 | 2-Bromobenzylzinc Bromide;2-Bromobenzylzinc Bromide, 0.5M In THF, Packaged Under Argon In Resealable Chemseal^T Bottles;2-BROMOBENZYLZINC BROMIDE, 0.5M SOLUTION IN TETRAHYDROFURAN;2-Bromobenzylzinc Bromide Solution 0.5 In THF | C7H6Br2Zn |
| 307496-31-7 | 3-Bromobenzylzinc Bromide;3-Bromobenzylzinc Bromide, 0.5M In THF, Packaged Under Argon In Resealable Chemseal^T Bottles;3-BROMOBENZYLZINC BROMIDE 0.5M &;3-Bromobenzylzinc Bromide Solution | C7H6Br2Zn |
| 307496-32-8 | 2,5-Difluorobenzylzinc Bromide;2,5-Difluorobenzylzinc Bromide, 0.5M In THF, Packaged Under Argon In Resealable Chemseal^T Bottles;2,5-Difluorobenzylzinc Bromide 0.5M Solution In THF;2,5-Difluorobenzylzinc Bromide Solution 0.5 In THF | C7H5BrF2Zn |
| 307496-33-9 | 2,6-Difluorobenzylzinc Bromide | |
| 307496-34-0 | (3,4-Difluorobenzyl)zinc bromide | C7H5BrF2Zn |
| 307496-37-3 | 2,4-Diamino-6-Mercapto-Pyrimidine Sulfate;2,4-Diamino-6-Mercaptopyrimidine Sulfate Salt;2,4-DIAMINO-6-MERCAPTO-PYRIMIDINE SULFATE;4-Diamino-6-Mercapto-Pyrimidine Sulfate | C4H8N4O4S2 |
| 307496-40-8 | 1,4-Bis[dimethyl[2-(5-norbornen-2-yl)ethyl]silyl]benzene | |
| 307503-19-1 | 3-Iodo-Imidazo[1,2-a]Pyridine;IMIDAZO[1,2-A]PYRIDINE, 3-IODO-;3-IODO-IMIDAZO[1,2-A]PYRIDINE | C7H5IN2 |
| 307510-92-5 | CFTR(inh)-172;3-[(3-Trifluoromethyl)phenyl]-5-[(4-carboxyphenyl)methylene]-2-thioxo-4-thiazolidinone; CFTR(inh)-172; Cystic fibrosis transmembrane conductance regulator inhibitor CFTR(inh)-172 | C18H10F3NO3S2 |
| 307511-65-5 | 2-Amino-4-(3,4-Dimethylphenyl)-3-Thiophenecarboxylic Acid Ethyl Ester;Ethyl 2-Amino-4-(3,4-Dimethylphenyl)Thiophene-3-Carboxylate(SALTDATA: FREE);3-THIOPHENECARBOXYLIC ACID, 2-AMINO-4-(3,4-DIMETHYLPHENYL)-, ETHYL ESTER;2-AMINO-4-(3,4-DIMETHYL-PHENYL)-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER | C15H17NO2S |
| 307512-22-7 | 2,3,5,6,7,8-Hexahydro-7-Methyl-3-(2-Propen-1-Yl)-2-Thioxo-[1]Benzothieno[2,3-d]Pyrimidin-4(1H)-One;[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE, 5,6,7,8-TETRAHYDRO-2-MERCAPTO-7-METHYL-3-(2-PROPENYL)-;3-Allyl-7-Methyl-2-Mercapto-5,6,7,8-Tetrahydro[1]Benzothieno[2,3-D]Pyrimidin-4(3H)-One, 96%;3-ALLYL-2-MERCAPTO-7-METHYL-5,6,7,8-TETRAHYDRO-3H-BENZO[4,5]THIENO[2,3-D]PYRIMIDIN-4-ONE | C14H16N2OS2 |
| 307512-33-0 | 5,6-Dimethyl-Thieno[2,3-d]Pyrimidine-4(3H)-Thione;THIENO[2,3-D]PYRIMIDINE-4(3H)-THIONE, 5,6-DIMETHYL-;5,6-DIMETHYLTHIENO[2,3-D]PYRIMIDINE-4(3H)-THIONE | C8H8N2S2 |
| 307512-34-1 | 5-(4-Methylphenyl)-Thieno[2,3-d]Pyrimidine-4(3H)-Thione | |
| 307531-71-1 | Hexafluoroacetyl-Praseodymium(III) | |
| 307531-73-3 | 6-Methylpicolinic Acid Hydrochloride;6-Methylpyridine-2-Carboxylic Acid, Hydrochloride Hydrate;6-METHYLPICOLINIC ACID HYDROCHLORIDE HYD;6-METHYLPICOLINIC ACID HYDROCHLORIDE | C7H10ClNO3 |
| 307531-74-4 | cis-1-Heptene-1,2-diboronic acid bis(pinacol) ester;2,2Μ-[(1Z)-1-Pentyl-1,2-Ethenediyl]Bis[4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane], 1-[Cis-1,2-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)] Heptene;2,2'-[(1Z)-1-Pentyl-1,2-Ethenediyl]Bis[4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane];1-CIS-1,2-BIS(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)HEPTENE | C19H36B2O4 |
| 307531-75-5 | cis-1-Pentene-1,2-diboronic acid bis(pinacol) ester;2,2Μ-[(1Z)-1-Propyl-1,2-Ethenediyl]Bis[4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane], 1-[Cis-1,2-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)] Pentene;2,2'-[(1Z)-1-Propyl-1,2-Ethenediyl]Bis[4,4,5,5-Tetramethyl-1,3,2-Dioxaborolanel;1-Cis-1,2-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxoboralan-2-Yl)Pentene | C17H32B2O4 |
| 307531-76-6 | N-Hydroxy-5-norbornene-2,3-dicarboximide perfluoro-1-butanesulfonate | |
| 307531-78-8 | (S)-(-)-1,1,1,2,2-Pentafluorododecan-3-ol | |
| 307531-82-4 | [2-(1,3-Dioxan-2-yl)ethyl]zinc bromide | C6H11BrO2Zn |
| 307531-83-5 | (1,3-Dioxolan-2-Ylethyl)Zinc Bromide;2-(1,3-Dioxolan-2-Yl)Ethylzinc Bromide, 0.5M In THF, Packaged Under Argon In Resealable Chemseal^T Bottles;2-(1,3-Dioxolan-2-Yl)]Ethyl]Zinc Bromide Solution 0.5 In THF;2-(1,3-Dioxolan-2-Yl)]Ethyl]Zinc Bromide Solution | C5H9BrO2Zn |
| 307531-88-0 | (S)-(+)-N-Boc-3-N-Fmoc-Aminopyrrolidine;(S)-1-BOC-3-FMOC-AMINOPYRROLIDINE;(S)-N-BOC-3-FMOC-AMINOPYRROLIDINE | C24H28N2O4 |
| 307531-89-1 | endo-3,7,14-Trifluoro-1,3,5,7,9,11,14-heptacyclopentyltricyclo[7.3.3.15,11]heptasiloxane | |
| 307531-90-4 | 1,3,5,7,9,11,13,15-Octakis(2-methylpropyl)-Tetracyclo[9.5.1.13,9.15,15]octasiloxane-7,13-diol | |
| 307531-92-6 | 1,3,5,7,9,11,14-Heptaisobutyltricyclo[7.3.3.15,11]heptasiloxane-endo-3,7,14-triol;1,3,5,7,9,11,14-HEPTAISOBUTYLTRICYCLO(7.;1 3 5 7 9 11 14-HEPTAISOBUTYLTRICYCLO;Isobutyltrisilanol-POSS(R) | C28H66O12Si7 |
| 307531-94-8 | 3-(3,5,7,9,11,13,15-Heptaisobutylpentacyclo[9.5.13,9.15,15.17,13]octasiloxan-1-yl)propyl methacrylate | |
| 307531-96-0 | Etoricoxib Impurity 19;2-methyl-5-[3-(4-methylsulfonylphenyl)furan-2-yl]pyridine | C17H15NO3S |
| 307532-01-0 | Methyl (S)-(-)-4-(tert-butyldimethylsilyloxy)-2-hydroxybutanoate | C11H24O4Si |
| 307532-03-2 | (R)-(-)-1-(4-Fluorophenoxy)-2-Propanol | |
| 307532-04-3 | (R)-(+)-1-Chloro-3-(4-fluorophenoxy)-2-propanol | |
| 307532-06-5 | (R)-(-)-2-(Dibenzylamino)-3-Phenyl-1-Propanol | |
| 307532-33-8 | Scandium(III) tris(2,2,6,6-tetramethyl-3,5-heptanedionate) hydrate | |
| 307538-42-7 | 6-Bromo-N-2-propen-1-yl-4-quinazolinamine;SMER 28 | C11H10BrN3 |
| 307543-71-1 | N-[(2-Hydroxy-1-naphthalenyl)methylene]-2-thiophenesulfonamide;IRE 1 Inhibitor I; STF 083010 | C15H11NO3S2 |
| 307545-27-3 | 3-[(3-Methylbenzyl)Thio]-1H-1,2,4-Triazole | C10H11N3S |
| 307548-90-9 | 2-[(6-Methyl-4-Oxo-1,2,3,4-Tetrahydrocyclopenta[c]Chromen-7-Yl)Oxy]Propanoic Acid;2-({10-me<wbr>thyl-7-ox<wbr>o-8-oxatr<wbr>icyclo[7.<wbr>4.0.02,6]<wbr>trideca-1<wbr>(9),2(6),<wbr>10,12-tet<wbr>raen-11-y<wbr>l}oxy)pro<wbr>panoic ac<wbr>id;2-(6-Meth<wbr>yl-4-oxo-<wbr>1,2,3,4-t<wbr>etrahydro<wbr>-cyclopen<wbr>ta[c]chro<wbr>men-7-ylo<wbr>xy)-propi<wbr>onic acid;2-(6-meth<wbr>yl-4-oxo-<wbr>1,2,3-tri<wbr>hydrocycl<wbr>openta[1,<wbr>2-c]chrom<wbr>en-7-ylox<wbr>y)propano<wbr>ic acid | C16H16O5 |
| 307549-54-8 | [(7-Methyl-4-Oxo-1,2,3,4-Tetrahydrocyclopenta[c]Chromen-9-Yl)Oxy]Acetic Acid;(7-Methyl<wbr>-4-oxo-1,<wbr>2,3,4-tet<wbr>rahydro-c<wbr>yclopenta<wbr>[c]chrome<wbr>n-9-yloxy<wbr>)-acetic <wbr>acid;[(7-methy<wbr>l-4-oxo-1<wbr>,2,3,4-te<wbr>trahydroc<wbr>yclopenta<wbr>[c]chrome<wbr>n-9-yl)ox<wbr>y]acetic <wbr>acid;[(7-Methy<wbr>l-4-oxo-1<wbr>,2,3,4-te<wbr>trahydroc<wbr>yclopenta<wbr>[c]-chrom<wbr>en-9-yl)o<wbr>xy]acetic<wbr> acid | C15H14O5 |
| 307554-62-7 | alpha9,alpha10-Dicarboxy-9,10-anthracenedipropanoic acid;9,10-Anthracenediylbis(methylene)dimalonic acid | C22H18O8 |
| 307557-56-8 | 2-[3-(Trifluoromethyl)Phenoxy]Acetohydrazide;2-[3-(Trifluoromethyl)phenoxy]acetohydrazide;MFCD03147377;ZINC02390392 | C9H9F3N2O2 |
| 307923-93-9 | N-Ethyl-N-(3-Methoxyphenyl)-beta-Alanine;3-(ethyl(3-methoxyphenyl)amino)propanoic acid;3-(ethyl-3-methoxyanilino)propanoic acid;3-[ethyl(3-methoxyphenyl)amino]propanoic acid | C12H17NO3 |
| 307926-51-8 | (S,S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride | C36H52AlClN2O2 |
| 307929-32-4 | 2-(3-Chlorophenyl)-4,6-diphenyl-1,3,5-triazine | C21H14ClN3 |
| 307951-53-7 | 4-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine | C8H7ClN2 |